In the current study, we used the Fat-1 mouse model to demonstrate that a targeted intervention to reduce obesity-associated inflammation by increasing the maternal n-3/n-6 tissue fatty acid ratio can prevent such an exposure without any manipulation of maternal weight, thereby reducing metabolic impairments in both the fetus and future adult offspring. The gene discussed is FAT1; the disease is obesity due to melanocortin 4 receptor deficiency.